Follow the 인바이오 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Chemicals sector, 인바이오 has logged 57 reports. Market capitalisation: €22.1bn. The latest transaction was filed on 21 July 2026 (Purchase). Among the most active insiders: 이혁재. All data is openly available.
52
Insider Decl.
n/a
Thresholds
€14,430
51 ops.
Buy Volume
n/a
n/a
Sell Volume
31Σ signal
Buys €14,430n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 14,631 of 29,063 companies
51.9
score / 100
Value
66
Quality
37
FCF yld9.2%
Earn yld4.6%
EV/EBITDA10.4x
ROE1.8%
Gross mgn35%
Net mgn3.0%
Debt/EBITDA4.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.